
Reuters UK
<img alt="" height="1" width="1" />
Advisers back Merck drug for some kidney patients
Reuters
This undated handout image, provided by Merck & Co. Inc. on March 9, 2009, shows the cholesterol drug Vytorin. By Alina Selyukh SILVER SPRING, Maryland (Reuters) - Health advisers on Wednesday unanimously recommended use of Merck & Co's ...
FDA panel backs expanded use of Merck's VytorinBusinessWeek
FDA Panel Says Vytorin Okay for Some Kidney Disease PatientsMedPage Today
FDA Advisory Committee Recommends Approval for Vytorin in Pre-Dialysis CKD ...Forbes
Bloomberg -TheHeart.Org -CBS MoneyWatch.com
all 43 news articles »
More...